Sex-specific versus overall clinical decision limits for Cardiac Troponin i and T for the diagnosis of acute myocardial infarction: A systematic review

Clinical Chemistry

Volumn 64, Issue 7, 2018, Pages 1034-1043

  Kimenai, Dorien M ^a   Janssen, Emma B N J ^a   Eggers, Kai M ^b   Lindahl, Bertil ^b   Den Ruijter, Hester M ^c   Bekers, Otto ^a   Appelman, Yolande ^d   Meex, Steven J R ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UPPSALA UNIVERSITY   (Sweden)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN I; TROPONIN T;

ACUTE HEART INFARCTION; CLINICAL DECISION MAKING; COMPARATIVE STUDY; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; MALE; REVIEW; SEX DIFFERENCE; SYSTEMATIC REVIEW; BLOOD; HEART INFARCTION; SENSITIVITY AND SPECIFICITY; SEX FACTOR; SURVIVAL RATE;

FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; SENSITIVITY AND SPECIFICITY; SEX FACTORS; SURVIVAL RATE; TROPONIN I; TROPONIN T;

EID: 85049406564     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2018.286781     Document Type: Review

References (55)

1. Pagidipati NJ, Peterson ED. Acute coronary syndromes in women and men. Nat Rev Cardiol 2016;13:471- 80.
2. Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart disease and stroke statistics-2017 update: A report from the American Heart Association. Circulation 2017;135:e146 - 603.
3. Madonis SM, Skelding KA, Roberts M. Management of acute coronary syndromes: Special considerations in women. Heart 2017;103:1638 - 46.
4. de Torbal A, Boersma E, Kors JA, van Herpen G, Deckers JW, van der Kuip DA, et al. Incidence of recognized and unrecognized myocardial infarction in men and women aged 55 and older: The Rotterdam Study. Eur Heart J 2006;27:729 -36.
5. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. J AmColl Cardiol 2012;60:1581-98.
6. Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 2016;37:267-315.
7. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined - A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959 - 69.
8. Panteghini M, Pagani F, Yeo KT, Apple FS, Christenson RH, Dati F, et al. Evaluation of imprecision for cardiac troponin assays at low-range concentrations. Clin Chem 2004;50:327-32.
9. Apple FS, Collinson PO, Biomarkers ITFoCAoC. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem 2012;58:54 - 61.
10. Mingels A, Jacobs L, Michielsen E, Swaanenburg J, Wodzig W, van Dieijen-Visser M. Reference population and marathon runner sera assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and I assays. Clin Chem 2009;55:101- 8.
11. Apple FS, Ler R, Murakami MM. Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin Chem 2012;58:1574 - 81.
12. Kimenai DM, Henry RM, van der Kallen CJ, Dagnelie PC, Schram MT, Stehouwer CD, et al. Direct comparison of clinical decision limits for cardiac troponin T and I. Heart 2016;102:610 - 6.
13. Wildi K, Gimenez MR, Twerenbold R, Reichlin T, Jaeger C, Heinzelmann A, et al. Misdiagnosis of myocardial infarction related to limitations of the current regulatory approach to define clinical decision values for cardiac troponin. Circulation 2015;131:2032- 40.
14. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Br Med J 2009;339:b2535.
15. Thygesen K, Mair J, Katus H, Plebani M, Venge P, Collinson P, et al. Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J 2010;31:2197-204.
16. Sandoval Y, Apple FS. The global need to define normality: The 99th percentile value of cardiac troponin. Clin Chem 2014;60:455- 62.
17. Rogers J, DuS, Yen J, Wiesner D, Workman R, Badciong J. Determination of a 99th percentile for the ARCHITECT STAT high sensitive troponin-I immunoassay using a robust statistical method. Clin Chem 2013;59:A225.
18. Saenger AK, Beyrau R, Braun S, Cooray R, Dolci A, Freidank H, et al. Multicenter analytical evaluation of a high-sensitivity troponin T assay. Clin Chim Acta 2011;412:748 -54.
19. Hickman PE, Koerbin G, Potter JM, Abhayaratna WP. Statistical considerations for determining highsensitivity cardiac troponin reference intervals. Clin Biochem 2017;50:502-5.
20. Ko DH, Jeong TD, Cho EJ, Lim J, Ji M, Lee K, et al. The 99th percentile values of six cardiac troponin assays established for a reference population using strict selection criteria. Clin Chim Acta 2017;464:1-5.
21. Mueller T, Egger M, Leitner I, Gabriel C, Haltmayer M, Dieplinger B. Reference values of galectin-3 and cardiac troponins derived from a single cohort of healthy blood donors. Clin Chim Acta 2016;456:19 -23.
22. Ungerer JP, Tate JR, Pretorius CJ. Discordance with 3 cardiac troponin I and T assays: Implications for the 99th percentile cutoff. Clin Chem 2016;62:1106 -14.
23. Abe N, Tomita K, Teshima M, Kuwabara M, Sugawa S, Hinata N, et al. Distribution of cardiac troponin I in the Japanese general population and factors influencing its concentrations. J Clin Lab Anal 2018;32:e22294.
24. Aw TC, Phua SK, Tan SP. Measurement of cardiac troponin I in serum with a new high-sensitivity assay in a large multi-ethnic Asian cohort and the impact of gender. Clin Chim Acta 2013;422:26 - 8.
25. Collinson PO, Gaze D, Goodacre S. The clinical and diagnostic performance characteristics of the high sensi- tivity Abbott cardiac troponin I assay. Clin Biochem 2015;48:275- 81.
26. Eggers KM, Apple FS, Lind L, Lindahl B. The applied statistical approach highly influences the 99th percentile of cardiac troponin I. Clin Biochem 2016;49:1109 -12.
27. Ji M, Moon HW, Hur M, Yun YM. Determination of high-sensitivity cardiac troponin I 99th percentile upper reference limits in a healthy Korean population. Clin Biochem 2016;49:756 - 61.
28. Koerbin G, Tate J, Potter JM, Cavanaugh J, Glasgow N, Hickman PE. Characterisation of a highly sensitive troponin I assay and its application to a cardio-healthy population. Clin Chem Lab Med 2012;50:871- 8.
29. KrintusM, Kozinski M, Boudry P, Capell NE, Koller U, Lackner K, et al. European multicenter analytical evaluation of the Abbott ARCHITECT STAT high sensitive troponin I immunoassay. Clin Chem Lab Med 2014;52:1657- 65.
30. Krintus M, Kozinski M, Boudry P, Lackner K, Lefevre G, Lennartz L, et al. Defining normality in a European multinational cohort: Critical factors influencing the 99th percentile upper reference limit for high sensitivity cardiac troponin I. Int J Cardiol 2015;187:256 - 63.
31. Krintus M, Kozinski M, Fabiszak T, Kuligowska-Prusinska M, Laskowska E, Lennartz L, et al. Impact of lipid markers and high-sensitivity C-reactive protein on the value of the 99th percentile upper reference limit for high-sensitivity cardiac troponin I. Clin Chim Acta 2016;462:193-200.
32. Li S, Zuo Y, Huang W. Establishment of a reference interval for high-sensitivity cardiac troponin I in healthy adults from the Sichuan area. Medicine (Baltimore) 2017;96:e6252.
33. Zeller T, Ojeda F, Brunner FJ, Peitsmeyer P, Munzel T, Binder H, et al. High-sensitivity cardiac troponin I in the general population- defining reference populations for the determination of the 99th percentile in the Gutenberg Health Study. Clin Chem Lab Med 2015;53:699 -706.
34. Aw T, Phua S, Lam C, Wong M. What are normal highsensitivity troponin-T values in a large multi-ethnic Asian population?. Blood Heart Circulation 2017;1:1-4.
35. Collinson PO, Heung YM, Gaze D, Boa F, Senior R, Christenson R, Apple FS. Influence of population selection on the 99th percentile reference value for cardiac troponin assays. Clin Chem 2012;58:219 -25.
36. Fan L, Yu P, Yu S, Gu Y, Zong M, Cai Y, Liu Z. Age-specific 99th percentile cutoff of high-sensitivity cardiac troponin T for early prediction of non-ST-segment elevation myocardial infarction (NSTEMI) in middle-aged patients. J Clin Lab Anal 2014;28:10 -5.
37. FranziniM, Lorenzoni V, Masotti S, Prontera C, Chiappino D, Latta DD, et al. The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. Clin Chim Acta 2015;438:376 - 81.
38. Gaggin HK, Dang PV, Do LD, deFilippi CR, Christenson RH, Lewandrowski EL, et al. Reference interval evaluation of high-sensitivity troponin T and N-terminal B-type natriuretic peptide in Vietnam and the US: The North South East West trial. Clin Chem 2014;60:758 - 64.
39. Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem 2010;56:254 - 61.
40. Gore MO, Seliger SL, Defilippi CR, Nambi V, Christenson RH, Hashim IA, et al. Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay. J Am Coll Cardiol 2014;63:1441- 8.
41. Gunsolus IL, Jaffe AS, Sexter A, Schulz K, Ler R, Lindgren B, et al. Sex-specific 99th percentiles derived from the AACC Universal Sample Bank for the Roche Gen 5 cTnT assay: Comorbidities and statistical methods influence derivation of reference limits. Clin Biochem 2017;50:1073-7.
42. Hammarsten O, Fu ML, Sigurjonsdottir R, Petzold M, Said L, Landin-Wilhelmsen K, et al. Troponin T percentiles from a random population sample, emergency room patients and patients with myocardial infarction. Clin Chem 2012;58:628 -37.
43. Yang S, Huai W, Qiao R, Cui L, Liu G, WuJ, et al. Age and gender tailored cutoff value of hs-cTnT contributes to rapidly diagnose acute myocardial infarction in chest pain patients. Clin Lab 2016;62:1451-9.
44. Eggers KM, Lindahl B. Impact of sex on cardiac troponin concentrations - A critical appraisal. Clin Chem 2017;63:1457- 64.
45. de Simone G, Devereux RB, Daniels SR, Meyer RA. Gender differences in left ventricular growth. Hypertension 1995;26:979 - 83.
46. de Lemos JA, Drazner MH, Omland T, Ayers CR, Khera A, Rohatgi A, et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 2010;304:2503-12.
47. Neeland IJ, Drazner MH, Berry JD, Ayers CR, deFilippi C, Seliger SL, et al. Biomarkers of chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general population. J Am Coll Cardiol 2013;61:187-95.
48. Jaffe AS, Apple FS. High-sensitivity cardiac troponin assays: Isn't it time for equality?. Clin Chem 2014;60:7-9.
49. Westerman S, Wenger NK. Women and heart disease, the underrecognized burden: Sex differences, biases, and unmet clinical and research challenges. Clin Sci 2016;130:551- 63.
50. Donaldson C, Eder S, Baker C, Aronovitz MJ, Weiss AD, Hall-Porter M, et al. Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation. Circ Res 2009;104:265-75.
51. Piro M, Della Bona R, Abbate A, Biasucci LM, Crea F. Sex-related differences in myocardial remodeling. J Am Coll Cardiol 2010;55:1057- 65.
52. Sheehan P, Blennerhassett J, Vasikaran SD. Decision limit for troponin I and assay performance. Ann Clin Biochem 2002;39:231- 6.
53. Twerenbold R, Boeddinghaus J, Nestelberger T, Wildi K, Rubini Gimenez M, Badertscher P, Mueller C. Clinical use of high-sensitivity cardiac troponin in patients with suspected myocardial infarction. J Am Coll Cardiol 2017;70:996 -1012.
54. Cullen L, Greenslade JH, Carlton EW, Than M, Pickering JW, Ho A, et al. Sex-specific versus overall cut points for a high sensitivity troponin I assay in predicting 1-year outcomes in emergency patients presenting with chest pain. Heart 2016;102:120 - 6.
55. Shah AS, Griffiths M, Lee KK, McAllister DA, Hunter AL, Ferry AV, et al. High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: Prospective cohort study. BMJ 2015;350:g7873.